Key Insights

Highlights

Success Rate

100% trial completion (above average)

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Research Network

Active Sponsors

  • LMC Diabetes & Endocrinology Ltd.1

Top Investigators

Related Conditions

  • Hyperkeratosis1
  • Onychomycosis1
  • Foot Deformities1
  • Foot Ulcer Diabetic1
  • Diabetes Mellitus Type 11

Activity Timeline